🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Investigational Drug Gaining Traction Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are urged to contact these profiles privately for source information, while also obtaining promotional offers.

Active Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with thousands of members share comparison images, injection guides and claims of rapid British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.

Learning About Retatrutide

This medication is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have warned that the distribution of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in users injecting products of unknown origin.

Some professionals stated the demand for retatrutide could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and customer laws, risking fines, legal action or prison.

Platform Response and Material Elimination

According to the social media company, the service has removed problematic material and banned related keywords and query recommendations. The organization said it was committed to maintaining the service safe and allocating resources in strengthening compliance measures.

Online Marketplace Activities

Investigations also discovered groups with up to nine thousand members selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, filled with images of slimming results, positive reviews and detailed instructions for mixing or administering at residence.

Within moments of entering one group, a vendor posted contact information, where most purchases occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Product Information and Costs

Within these groups, messages display dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use pens usually priced at £160 for 20mg. When questioned how long a pen should be used, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Moderation and Safety Measures

A spokesperson for Telegram said it actively moderated harmful content on its platform including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are injecting materials they cannot confirm. Even if the research behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has previously seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency globally. “Therefore at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet authorized … may expose patients to possibly significant health risks”.